Health & Education

Portugal cuts antibiotic use 5.2% since 2019, but Klebsiella resistance more than doubles

Health bodies say Portugal's antibiotic consumption fell 5.2% between 2019 and 2025, while infections from carbapenem-resistant Klebsiella pneumoniae more than doubled over the same period.

AI text based on reports by Observador, SAPO and Correio da Manha. Published . How it is made

For membersThe first 30 seconds for everyone. Synthetic voice (AI).

In brief

Consumption falls toward the 2030 target

Portugal's total antibiotic consumption dropped from 19.3 defined daily doses (DHD) per 1,000 inhabitants per day in 2019 to 18.3 in 2025, a fall of 5.2%. Infarmed, the Directorate-General of Health (DGS) and the National Health Institute Dr. Ricardo Jorge (INSA) published the figures in a joint statement on European Antibiotic Day. The national target for 2030 is 17.6 DHD, so roughly four more percentage points still need to come off, Infarmed says in its monthly Deep Dive publication. Preliminary first-half 2026 data point to a continued decline, which keeps the target possible if current prudent-use measures are maintained. Antibiotics recommended as first-choice treatment for many common infections made up 61.9% of consumption, below the European goal of at least 65%. The three bodies also warned that resistance still demands action.

Portugal antibiotic consumption, DHD per 1,000 inhabitants per dayDHD per 1,000 inhabitants per day
2019
19.3 DHD per 1,000 inhabitants per day
2025
18.3 DHD per 1,000 inhabitants per day
2030 target
17.6 DHD per 1,000 inhabitants per day

Data from the article text

“Although some bacterial resistance indicators have improved, others still call for integrated action on infection prevention and the appropriate use of antimicrobials.”

Infarmed, DGS and INSA

Resistance indicators split

Three of the resistance indicators carry national targets under the EU framework for 2030, and Portugal has already met the one for MRSA. Bloodstream infections caused by methicillin-resistant Staphylococcus aureus fell 31.3% between 2019 and 2025, from 11.39 to 7.83 cases per 100,000 inhabitants, beating the 18% reduction target. The other two moved the wrong way. Bloodstream infections from Escherichia coli resistant to third-generation cephalosporins rose 31.9%, against a goal of a 12% cut, while Klebsiella pneumoniae resistant to carbapenems more than doubled.

MRSA bloodstream infection incidence in Portugalcases per 100,000 inhabitants
2019
11.39 cases per 100,000 inhabitants
2025
7.83 cases per 100,000 inhabitants

Data from the article text

Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in Portugalcases per 100,000 inhabitants
2019
2.93 cases per 100,000 inhabitants
2025
6.06 cases per 100,000 inhabitants

Data from the article text

The Klebsiella rise went from 2.93 to 6.06 cases per 100,000 inhabitants, an increase of 107%, which takes Portugal further from its 5% reduction target. The DGS calls the trend particularly worrying and lists it as a priority for the national Infection Prevention and Control and Antimicrobial Resistance Programme (PPCIRA). Carbapenems are last-line antibiotics, so resistance to them sharply narrows treatment options, and the DGS notes that many European countries face the same picture. The figures cover only bloodstream infections, not every infection caused by these microorganisms.

Europe's infection burden and hospital care

An ECDC report released on Tuesday, 17 November estimates that more than 35,000 people die each year in the European Union from infections caused by antibiotic-resistant microorganisms, a toll comparable to flu, tuberculosis and HIV combined. Each year, 4.3 million patients acquire at least one healthcare-associated infection during a hospital stay. EU antibiotic consumption fell 5% in 2025 compared with 2019, but that progress falls short of the 20% reduction goal for 2030. The agency considers it unlikely that EU resistance targets will be met by 2030 without faster, stronger public health action. Over 70% of the public health impact of resistance comes from healthcare-associated infections caused by multidrug-resistant bacteria, and half of those could be prevented with proper infection control.

“One in three microorganisms detected in healthcare-associated infections are bacteria resistant to important antibiotics, limiting treatment options.”

ECDC

In Portugal, the DGS told Lusa that overcrowding, patient vulnerability and gaps in infection control in health services can help resistant bacteria spread, so prevention requires more than cutting prescriptions. The DGS put it this way:

“The goal is not just to prescribe less, but to prescribe better.”

DGS

Children and the gut

On Wednesday, 18 November, the DGS warned that fever, cough or sore throat do not on their own mean a child needs antibiotics, because most childhood respiratory infections are viral. In Portugal, systemic antibiotics require a prescription, and the DGS advises against using leftover medicines or drugs prescribed to someone else. The DGS also said that expanding flu vaccination to children up to age four and introducing RSV immunisation could help cut antibiotic use, although that was not their aim.

Gastroenterologists José Pedro Rodrigues and Mónica Velosa, speaking during World Antibiotic Awareness Week (18 to 24 November), warned that antibiotics cannot tell harmful bacteria from beneficial ones, so beneficial gut species can drop sharply or vanish for months after broad-spectrum treatment. The effect depends on drug type, dose, treatment length and repeated courses. Rodrigues said Portugal still prescribes and uses broad-spectrum antibiotics above European averages, and urged that hospital stewardship programmes extend to primary care, emergency departments, continuing care and the private sector.

Ask about this text

Sources and context

Places
Portugal

Pollar is free and carries no ads in the text. Its members keep it going.

Support Pollar